FIELD: medicine.
SUBSTANCE: invention refers to medicine, and aims at prevention of the purulent complications of pancreatonecrosis. Patient's intestinal mucosal permeability is evaluated by the mannitol/lactulose test. If the urine mannitol/lactulose relation falls within the range of 0.03 to 0.05, a nasojejunal catheter is used to introduce 0.25% Derinat 10ml dissolved in physiological saline 50 ml into the intestine. If the urine mannitol/lactulose relation exceeds 0.05, 0.25% Derinat 20ml dissolved in physiological saline 50 ml is introduced into the intestine using the nasojejunal catheter. The preparation is introduced once a day for 3-4 days.
EFFECT: method enables more effective prevention of the purulent complications of pancreatonecrosis with the improved intestinal mucosa permeability.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ENDOVASCULAR PREVENTION OF ENDOTOXINEMIA IN LAPAROSCOPIC INTERVENTIONS IN PATIENTS WITH ACUTE ABDOMINAL PATHOLOGY, COMPLICATED WITH PERITONITIS | 2013 |
|
RU2525670C1 |
| METHOD FOR TREATING POSTOPERATIONAL PURULENT-INFLAMMATORY COMPLICATIONS INDUCED BY CROSS INFECTION | 2003 |
|
RU2246273C2 |
| METHOD FOR IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS WITH CONCOMITANT TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2763672C1 |
| METHOD FOR TREATING CHRONIC INFLAMMATORY DISEASES | 2002 |
|
RU2216328C1 |
| METHOD FOR PREOPERATIVE CORRECTION OF RESPIRATORY DISORDERS IN PATIENTS SUFFERING COLORECTAL CANCER | 2013 |
|
RU2526828C1 |
| METHOD FOR TREATING FEMALE CHRONIC CYSTITIS CASES | 2005 |
|
RU2295350C1 |
| METHOD OF TREATING PANCREATONECROSIS | 2010 |
|
RU2424010C1 |
| SODIUM AMINODIHYDROPHTHALAZINEDIONE SOLUTION FOR INTRAVENOUS ADMINISTRATION | 2023 |
|
RU2821033C1 |
| METHOD OF TREATING PURULENT-NECROTIC PANCREONECROSIS | 2010 |
|
RU2446756C1 |
| TOPICAL USE OF DIOXIDIN FOR TREATMENT OF OTOLARYNGOLOGICAL DISEASES | 2022 |
|
RU2809120C1 |
